Walleye Trading
LGND icon

Walleye Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Walleye Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$21.4K – 4412
2024
Q4 		$21.4K Buy
+200
New +$22.6K ﹤0.01% 3943
2024
Q2 		– Sell
-4,900
Closed -$358K – 4635
2024
Q1 		$358K Sell
4,900
-3,300
-40% -$243K ﹤0.01% 3043
2023
Q4 		$586K Buy
+8,200
New +$484K ﹤0.01% 2937
2022
Q2 		– Sell
-3,206
Closed -$225K – 5428
2022
Q1 		$225K Sell
3,206
-6,893
-68% -$500K ﹤0.01% 3692
2021
Q4 		$973K Buy
10,099
+8,336
+473% +$770K ﹤0.01% 2261
2021
Q3 		$153K Buy
+1,763
New +$136K ﹤0.01% 4098
2021
Q2 		– Sell
-962
Closed -$91K – 5370
2021
Q1 		$91K Buy
+962
New +$90.9K ﹤0.01% 4140
2020
Q3 		– Sell
-3,206
Closed -$224K – 4403
2020
Q2 		$224K Buy
+3,206
New +$203K ﹤0.01% 2987
2020
Q1 		– Sell
-1,282
Closed -$83K – 4293
2019
Q4 		$83K Buy
+1,282
New +$85.7K ﹤0.01% 3638
2019
Q1 		– Sell
-321
Closed -$27K – 4500
2018
Q4 		$27K Sell
321
-6,572
-95% -$701K ﹤0.01% 4282
2018
Q3 		$1.18M Buy
6,893
+2,885
+72% +$435K 0.01% 1904
2018
Q2 		$518K Buy
+4,008
New +$447K ﹤0.01% 2811

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's LGND Position: Q4 2023 in Review

Walleye Trading sold out of Ligand Pharmaceuticals (LGND) in Q4 2023, closing a stake of 132 shares — an estimated $7.79K sold.

Walleye Trading first reported a position in LGND in Q2 2015 and held it in 4 quarters. The position peaked at $260K in Q1 2022. 211 funds tracked by Wall St. Rank hold LGND as of Q4 2023.

  • Walleye Trading reported no remaining Ligand Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 132 Ligand Pharmaceuticals shares in Q4 2023, an estimated $7.79K.
  • Walleye Trading first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Walleye Trading's Ligand Pharmaceuticals position peaked at $260K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.